Connecting METTL3 and intratumoural CD33+ MDSCs in predicting clinical outcome in cervical cancer
Abstract Background Methyltransferase-like 3 (METTL3) is a member of the m6A methyltransferase family and acts as an oncogene in cancers. Recent studies suggest that host innate immunity is regulated by the enzymes controlling m6A epitranscriptomic changes. Here, we aim to explore the associations b...
Main Authors: | Huan-he Ni, Lin Zhang, He Huang, Shu-qin Dai, Jiang Li |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-10-01
|
Series: | Journal of Translational Medicine |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12967-020-02553-z |
Similar Items
-
Characterization of METTL7B to Evaluate TME and Predict Prognosis by Integrative Analysis of Multi-Omics Data in Glioma
by: Xiaochuan Chen, et al.
Published: (2021-09-01) -
METTL3 increases cisplatin chemosensitivity of cervical cancer cells via downregulation of the activity of RAGE
by: Ruyi Li, et al.
Published: (2021-09-01) -
Identification of a novel six‐gene signature with potential prognostic and therapeutic value in cervical cancer
by: Xinyu Qu, et al.
Published: (2021-10-01) -
The study of METTL3 and METTL14 expressions in childhood ETV6/RUNX1‐positive acute lymphoblastic leukemia
by: Congcong Sun, et al.
Published: (2019-10-01) -
Upregulation of METTL3 Expression Predicts Poor Prognosis in Patients with Esophageal Squamous Cell Carcinoma
by: Xia TL, et al.
Published: (2020-07-01)